Literature DB >> 18848621

CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia.

Amanda L Jones1, Elizabeth G Holliday, Bryan J Mowry, Duncan E McLean, John J McGrath, Michael P Pender, Judith M Greer.   

Abstract

Associations between a single-nucleotide polymorphism (SNP) in exon 1 of the cytotoxic T-lymphocyte antigen-4 (CTLA4) gene and schizophrenia in a Korean population have been previously described. The current study investigated whether a similar link occurs in a Caucasian population with schizophrenia. One hundred and twenty-two age- and sex-matched pairs of people with DSM-III-R diagnosis of schizophrenia and healthy controls were included in this study. Three previously described SNPs (from the promoter, exon 1 and 3' UTR) of the CTLA4 gene were analysed. In the entire sample, we detected no allelic or genotypic association for any of the three SNPs. Given documented gender differences in incidence of schizophrenia, we conducted separate analyses of male and female participants. In males, both the promoter region SNP (-318C/T) and the 3' UTR SNP demonstrated nominally significant association with schizophrenia. The 3' UTR SNP remained significant following correction for multiple testing (permuted P=0.046). In addition, all possible haplogenotypes showed significant association with disease in males with two--both containing the 3' UTR SNP--remaining significant following correction for the genotypic tests of all SNPs and haplogenotypes in males. These results suggest a role for the 3' UTR SNP and/or variants in high linkage disequilibrium with this SNP in the pathogenesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848621     DOI: 10.1016/j.bbi.2008.09.008

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  4 in total

1.  Schizophrenia among patients with systemic lupus erythematosus: population-based cross-sectional study.

Authors:  S Tiosano; A Farhi; A Watad; N Grysman; R Stryjer; H Amital; D Comaneshter; A D Cohen; D Amital
Journal:  Epidemiol Psychiatr Sci       Date:  2016-07-26       Impact factor: 6.892

2.  Evaluation of polymorphism, hypermethylation and expression pattern of CTLA4 gene in a sample of Iranian patients with schizophrenia.

Authors:  Dor Mohammad Kordi-Tamandani; Shahram Vaziri; Nahid Dahmardeh; Adam Torkamanzehi
Journal:  Mol Biol Rep       Date:  2013-05-11       Impact factor: 2.316

3.  Altered expression of mRNA profiles in blood of early-onset schizophrenia.

Authors:  Yong Xu; Yin Yao Shugart; Guoqiang Wang; Zaohuo Cheng; Chunhui Jin; Kai Zhang; Jun Wang; Hao Yu; Weihua Yue; Fuquan Zhang; Dai Zhang
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

4.  Single-nucleotide Polymorphism of CTLA-4 (rs5742909) in Correlation with Schizophrenia Risk Factor.

Authors:  Riyadi Sumirtanurdin; James P Laksono; Haafizah Dania; Fitri N Ramadhani; Dyah A Perwitasari; Rizky Abdulah; Melisa I Barliana
Journal:  J Pharm Bioallied Sci       Date:  2019-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.